Hennion & Walsh Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,763
| Closed | -$2.77M | – | 894 |
|
|
2023
Q4 | $2.77M | Buy |
8,763
+739
| +9% | +$234K | 0.16% | 186 |
|
|
2023
Q3 | $1.36M | Buy |
8,024
+218
| +3% | +$36.9K | 0.09% | 285 |
|
|
2023
Q2 | $1.69M | Sell |
7,806
-223
| -3% | -$48.4K | 0.1% | 245 |
|
|
2023
Q1 | $1.46M | Buy |
8,029
+114
| +1% | +$20.7K | 0.09% | 274 |
|
|
2022
Q4 | $1.56M | Buy |
7,915
+1,034
| +15% | +$203K | 0.1% | 251 |
|
|
2022
Q3 | $1.55M | Buy |
6,881
+3,072
| +81% | +$691K | 0.1% | 234 |
|
|
2022
Q2 | $482K | Buy |
+3,809
| New | +$482K | 0.03% | 491 |
|